ClinicalTrials.Veeva

Menu
I

Ibamedica | Santa Fe, Argentina

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 1291583
Buloxibutid
Verekitug
Brenipatide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 4 total trials

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

The purpose of this study is to assess the efficacy and safety of verekitug (UPB-101) in participants with moderate-to-severe Chronic Obstructive Pul...

Enrolling
Chronic Obstructive Pulmonary Disease
Other: Placebo
Drug: Verekitug

The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with mod...

Enrolling
Asthma
Drug: Brenipatide
Drug: Placebo

The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and phar...

Enrolling
Idiopathic Pulmonary Fibrosis (IPF)
Drug: Placebo
Drug: Buloxibutid

This study is open to adults and adolescents aged 12 to under 18 with bronchiectasis. People can participate in this study if they produce sputum and...

Enrolling
Bronchiectasis
Drug: Placebo matching BI 1291583
Drug: BI 1291583

Trial sponsors

Boehringer Ingelheim logo
Lilly logo
U
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems